Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects - Concepedia

Concepedia

Publication | Closed Access

Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects

58

Citations

37

References

2006

Year

Ji Young Park, Kyoung‐Ah Kim, Per-Ola Park, O LEE, Daehee Kang, J SHON, K LIU, Jae‐Gook Shin

Clinical Pharmacology & Therapeutics

Abstract

The CYP3A5*3 genotype affects the disposition of alprazolam and thus influences the plasma levels of alprazolam.

References

	Year	Citations

Page 1